2INVEST AGNA O.N. news, videos and press releases
For more news please use our advanced search feature.
2INVEST AGNA O.N. - More news...
2INVEST AGNA O.N. - More news...
- DGAP-News: 4basebio AG: 4basebio comments on the takeover bid of Sparta AG
- DGAP-Adhoc: 4basebio AG announces process for spin-off and separate stock market listing for its DNA business
- DGAP-News: 4basebio AG: 4basebio AG reports first six months of 2020 financial results
- DGAP-News: 4basebio AG: 4basebio informs about takeover bid by Sparta AG
- DGAP-News: 4basebio AG: 4basebio reports on results of Annual General Meeting 2020
- DGAP-News: 4basebio AG: Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribution receives funding from 'la Caixa' Banking Foundation
- DGAP-News: 4basebio AG: 4basebio AG reports first quarter 2020 financial results
- DGAP-News: 4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financial Guidance Met
- DGAP-News: 4basebio AG: 4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection
- DGAP-Adhoc: 4basebio AG: 4basebio AG resolves on capital reduction by way of redemption of approx. 5.2 million treasury shares in accordance with the authorizing resolution of the general meeting
- DGAP-News: 4basebio AG: 4basebio AG announces allotment ratio and final number of shares for the share buy back
- DGAP-News: 4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back
- DGAP-News: 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares
- DGAP-Adhoc: 4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares
- DGAP-News: 4basebio AG: 4basebio AG decides to buy back 2 million treasury shares
- DGAP-Adhoc: 4basebio AG: 4basebio AG decides to buy back 2 million treasury shares for further use in accordance with the authorizing resolution
- DGAP-News: 4basebio AG: Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB
- DGAP-News: Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction
- DGAP-News: Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG
- DGAP-News: Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main
- DGAP-News: Expedeon AG: Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website
- DGAP-News: Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business
- DGAP-Adhoc: Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business
- DGAP-News: Expedeon AG: Expedeon AG reports third quarter 2019 financial results with strongest ever revenues and EBITDA
- DGAP-News: Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019
- DGAP-Adhoc: Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019